Metabolic Profile in Active Female Students Users and Non-Users Combined Oral Contraceptives

被引:0
作者
Malara, Marzena [1 ]
Keska, Anna [1 ]
Tkaczyk, Joanna [1 ]
Lutoslawska, Grazyna [1 ]
机构
[1] Jozef Pilsudski Univ Phys Educ, Warsaw, Poland
关键词
Combined Contraceptives; Physical Activity; Lipoproteins; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DENSITY; CORTISOL; TESTOSTERONE; CHOLESTEROL; DESOGESTREL; ESTROGEN;
D O I
10.29252/aassjournal.835
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background. Metabolic changes induced by combined oral contraceptives (COC) use is regularly active in females. Objectives. Analyzing blood cortisol and other biochemical variables in active (COC) users and non-users. Methods. A total of 123 active female students (25 COC users and 98 non-users) volunteered to participate in the study. The COC users declared 2-3 years of using different types of combined the fourth generation COC pills. In all participants' body composition, physical activity and dietary habits were determined. Circulating cortisol and insulin were determined using standard radioimmunoassay techniques. Plasma glucose and lipoproteins were determined using colorimetrical methods. To evaluate the health risk ratio of total cholesterol to HDL-cholesterol (Castelli index I) and LDL-cholesterol to HDL-cholesterol (Castelli index II) were calculated. Results. There were no between-groups differences in body composition and dietary habits. The COC users had markedly elevated plasma cortisol (p < 0.001), triacylglycerols (TG) (p < 0.001), total cholesterol (TC) (p < 0.002) and HDL-C (p < 0.040) with no effect on glucose, LDL-cholesterol (LDL-C) and TC-to HDL-C ratio. In contrast, the LDL-C to HDL-C ratio in COC users was lower vs. non-users (p < 0.002). COC users were characterized by a higher frequency of elevated TC (p < 0.001) and HDL-C (p < 0.040). However, in all participants Castelli index I and II were within the accepted limits suggesting a low risk of cardiovascular disease. Conclusion. In COC users regular physical activity does not prevent changes in circulating biochemical variables, however, these changes did not affect cardiovascular risk which is low and similar to that noted in active non-users.
引用
收藏
页数:7
相关论文
共 48 条
[41]   A Healthy Lifestyle Index Is Associated With Reduced Risk of Colorectal Adenomatous Polyps Among Non-Users of Non-Steroidal Anti-Inflammatory Drugs [J].
Tabung, Fred K. ;
Steck, Susan E. ;
Burch, James B. ;
Chen, Chin-Fu ;
Zhang, Hongmei ;
Hurley, Thomas G. ;
Cavicchia, Philip ;
Alexander, Melannie ;
Shivappa, Nitin ;
Creek, Kim E. ;
Lloyd, Stephen C. ;
Hebert, James R. .
JOURNAL OF PRIMARY PREVENTION, 2015, 36 (01) :21-31
[42]   The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives [J].
Burnhill, MS .
INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 1999, 44 (01) :19-30
[43]   Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone) [J].
Podfigurna, A. ;
Meczekalski, B. ;
Petraglia, F. ;
Luisi, S. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (04) :483-492
[44]   Secondary adrenal insufficiency and pituitary dysfunction in oral/transdermal opioid users with non-cancer pain [J].
Lamprecht, Andrea ;
Sorbello, Jane ;
Jang, Christina ;
Torpy, David J. ;
Inder, Warrick J. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (06) :353-362
[45]   Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial [J].
Wang, Qiu-Yi ;
Song, Yong ;
Huang, Wei ;
Xiao, Li ;
Wang, Qiu-Shi ;
Feng, Gui-Mei .
CHINESE MEDICAL JOURNAL, 2016, 129 (08) :883-890
[46]   Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta analysis comparing products containing cyproterone acetate with third generation progestins [J].
Amiri, Mina ;
Tehrani, Fahimeh Ramezani ;
Nahidi, Fatemeh ;
Kabir, Ali ;
Azizi, Fereidoun ;
Carmina, Enrico .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 73 :22-35
[47]   Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study [J].
Haarala, Atte ;
Eklund, Carita ;
Pessi, Tanja ;
Lehtimaki, Terho ;
Huupponen, Risto ;
Jula, Antti ;
Viikari, Jorma ;
Raitakari, Olli ;
Hurme, Mikko .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2009, 69 (02) :168-174
[48]   SKINFOLD AND BODY CIRCUMFERENCES AS MEASURES OF BODY-FAT PATTERNING IN A FRENCH FEMALE ACTIVE POPULATION - RELATIONSHIPS WITH THE METABOLIC RISK PROFILE [J].
BONITHONKOPP, C ;
RAISON, J ;
EGLOFF, M ;
GUYGRAND, B ;
DUCIMETIERE, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (06) :475-482